Isothermal Nucleic Acid Amplification Technology Market Share, Size, Trends, Segments And Forecast By 2024-32


(MENAFN- IMARC Group) The latest report by IMARC Group, titled“ Isothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032 “, The global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.

Isothermal nucleic acid amplification technology, in contrast to traditional methods, facilitates the amplification of DNA or RNA sequences at a consistent temperature. Its significance in diagnostics, particularly for detecting infectious pathogens using nucleic acids as biomarkers, is increasingly acknowledged. This method offers simplicity, rapidity, and cost-effectiveness, making it well-suited for point-of-care (POC) diagnostics, especially in settings with limited resources. Techniques such as loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), strand displacement amplification (SDA), rolling circle amplification (RCA), and recombinase polymerase amplification (RPA) are encompassed within this approach. Notable advantages include the availability of miniaturized sensors, the capability for in situ diagnosis, and alignment with the World Health Organization's ASSURED criteria, thereby enhancing their utility for swift and accurate molecular diagnostics.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market/requestsample

Isothermal
Nucleic Acid Amplification Technology Market Trends and Drivers:

The rapid expansion of the global market for isothermal nucleic acid amplification technology stems primarily from the increasing demand for quick and accurate molecular diagnostics. Isothermal amplification methods offer distinct advantages over traditional PCR by consistently amplifying nucleic acids at a constant temperature, eliminating the need for expensive thermal cyclers and complex laboratory setups. This characteristic makes them particularly attractive in areas with limited resources and infrastructure for advanced molecular diagnostics. Additionally, the rising prevalence of infectious diseases, including those caused by viruses, bacteria, and parasites, is driving the need for efficient and accessible diagnostic solutions, serving as another significant driver for market growth. Furthermore, isothermal nucleic acid amplification techniques hold great promise in detecting infectious agents, facilitating timely and precise diagnoses, thereby further driving market expansion. Renowned for their high sensitivity and specificity, these methods enable the detection of targets with minimal false-positive or false-negative results. Moreover, the ability to conduct rapid on-site diagnostics using isothermal amplification technology enhances patient care, infection control, and disease surveillance, propelling market advancement. Furthermore, the increasing focus on personalized medicine and precise diagnostics is increasing the demand for sophisticated molecular technologies that can identify specific genetic variations or mutations associated with various conditions, thereby fostering a positive market trajectory.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

  • Instruments
  • Reagents

Breakup by Technology:

  • Helicase-Dependent Amplification (HDA)
  • Nicking Enzyme Amplification Reaction (NEAR)
  • Loop-Mediated Isothermal Amplification (LAMP)
  • Strand Displacement Amplification (SDA)
  • Nucleic Acid Sequence-Based Amplification (NASBA)
  • Transcription Mediated Amplification (TMA)
  • Single Primer Isothermal Amplification (SPIA)
  • Others

Breakup by Application:

  • Infectious Disease Diagnosis
    • Hepatitis
    • CT/NG
    • HIV
    • Influenza
    • Others
  • Blood Screening
  • Others

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Abbott Laboratories
  • bioMérieux SA
  • Becton
  • Dickinson and Company
  • Eiken Chemical Co. Ltd.
  • Hologic Inc., Meridian Bioscience Inc.
  • OptiGene Limited
  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • Ustar Biotechnologies Ltd.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email:

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163

MENAFN29022024004122016232ID1107916748


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.